Pfizer Under Pressure After Halting Drug
The world's largest drugmaker said Saturday that an independent board monitoring a study for cholesterol treatment torcetrapib recommended that the work end because of an unexpected number of deaths.
0 Comments:
Post a Comment
<< Home